← Back to all trials
Completed
NCT07399288
Postherpetic Neuralgia After Herpes Zoster and Incident Dementia Risk
Conditions: Herpes Zoster, Dementia, Postherpetic Neuralgia (PHN)
Sex: All
Ages: 40 Years – 120 Years
Healthy volunteers: No
Enrollment: 73404
Sponsor: China Medical University Hospital
Location: China Medical University Hospital Taichung Taichung City
Summary
This retrospective observational cohort study uses de-identified electronic health record data from the TriNetX Global Collaborative Network to evaluate whether postherpetic neuralgia after herpes zoster is associated with an increased risk of incident dementia. Adults aged 40 to 120 years with incident herpes zoster between 1 October 2015 and 31 December 2024 are identified using diagnostic codes. Postherpetic neuralgia is defined by International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) codes B02.22 or B02.29 recorded between 90 and 365 days after the index herpes zoster date, and comparators have no such codes between 90 and 365 days after index. The primary analysis uses 1:1 propensity score matching and a 365-day landmark design, including only individuals alive and free of dementia at the landmark. Time-to-event analyses estimate hazard ratios for incident dementia and related outcomes.
Eligibility Criteria
Inclusion Criteria:
* Adults aged 40 to 120 years with an incident herpes zoster diagnosis recorded between 1 October 2015 and 31 December 2024 in the TriNetX network.
* A 3-year washout period with no recorded herpes zoster diagnosis before the index date.
* Eligible for analysis at the 365-day landmark after the index date, defined as being alive and free of the specified outcome at the landmark.
Exclusion Criteria:
* Any record of the specified outcome before the 365-day landmark.
* Missing data elements required to define exposure status within the prespecified time window.
Source: ClinicalTrials.gov (NCT07399288). StuddyBuddy aggregates publicly available trial information.